Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell Q3 Loss After Financial Items Narrows To SEK 11.1 Mln

Oct 27 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL AB (PUBL) INTERIM REPORT JANUARY 1ST TO SEPTEMBER
30TH,
2022
    * Q3 NET SALES AMOUNTED TO 10,401 (6,029) KSEK
    * Q3 PROFIT AFTER FINANCIAL ITEMS AMOUNTED TO -11,069
(-17,774)
KSEK
    * Q3 CASH FLOW FROM OPERATING ACTIVITIES FOR PERIOD AMOUNTED
TO
-1,856 (-7,810) KSEK

Source text for Eikon:  ID:nMFN6sqv62 
Further company coverage:  AROC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on IDL Diagnostics AB (publ)

See all news